Turnstone Biologics
Bernhard Fox is on the Scientific Advisors at Turnstone Biologics. He is also the Chief at Laboratory of Molecular and Tumor Immunology.
This person is not in the org chart
This person is not in any offices
Turnstone Biologics
Turnstone Biologics, a privately held clinical stage biotech company, is developing breakthrough cancer immunotherapies by advancing two leading and complementary platforms that drive innate and adaptive tumor immunity, to provide benefit to the millions of cancer patients underserved by current treatment options.